solo per uso di ricerca

Cardiac Troponin I Antibody [L9G3]

N. Cat.: F2021

    Applicazione: Reattività:
    • F2021-wb
      Lane 1: Human Cardiac Troponin I Recombinant Protein

    Elementi essenziali dellesperimento

    WB
    Recommended wet transfer conditions: 200 mA, 60 min.
    Recommended WB dilution ratio: 1:100000

    Informazioni sullutilizzo

    Diluizione
    1:100000 - 1:1000000
    1:50
    1:250 - 1:500
    1:50
    Applicazione
    WB, IP, IHC, FCM
    Reattività
    Human
    Fonte
    Rabbit Monoclonal Antibody
    Tampone di conservazione
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Conservazione (dalla data di ricezione)
    -20°C (avoid freeze-thaw cycles), 2 years
    PM previsto PM osservato
    24 kDa 28 kDa
    *Perché i pesi molecolari previsti e reali differiscono?
    Le seguenti ragioni possono spiegare le differenze tra il peso molecolare della proteina previsto e quello reale.
    Controllo positivo Human fetal heart; Human heart; Human cardiac muscle tissue; Fetal heart cells; A-673 cells
    Controllo negativo

    Metodi sperimentali

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 60 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:100000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IHC
    Experimental Protocol:
     
    Deparaffinization/Rehydration
    1. Deparaffinize/hydrate sections:
    2. Incubate sections in three washes of xylene for 5 min each.
    3. Incubate sections in two washes of 100% ethanol for 10 min each.
    4. Incubate sections in two washes of 95% ethanol for 10 min each.
    5. Wash sections two times in dH2O for 5 min each.
    6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
     
    Staining
    1. Wash sections in dH2O three times for 5 min each.
    2. Incubate sections in 3% hydrogen peroxide for 10 min.
    3. Wash sections in dH2O two times for 5 min each.
    4. Wash sections in wash buffer for 5 min.
    5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
    6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
    7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
    8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
    9. Wash sections three times with wash buffer for 5 min each.
    10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
    11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
    12. Immerse slides in dH2O.
    13. If desired, counterstain sections with hematoxylin.
    14. Wash sections in dH2O two times for 5 min each.
    15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
    16. Mount sections with coverslips and mounting medium.
     

    Datasheet & SDS

    Descrizione biologica

    Specificità
    Cardiac Troponin I Antibody [L9G3] detects endogenous levels of total Cardiac Troponin I protein.
    Localizzazione subcellulare
    Cardiac myofibril, Cytosol, Sarcomere
    Uniprot ID
    P19429
    Clone
    L9G3
    Sinonimo
    TNNC1, TNNI3, Cardiac troponin I
    Background
    Cardiac Troponin C (cTnC), encoded by TNNC1, is the 161-amino-acid Ca²⁺-sensing subunit of the heterotrimeric troponin complex (with cTnI and cTnT) on cardiac thin filaments, linking sarcoplasmic reticulum Ca²⁺ transients to actin-myosin cross-bridge cycling for excitation-contraction coupling in cardiomyocytes. It comprises an N-terminal regulatory domain (cNTnC, residues 1–77) with a single functional low-affinity EF-hand site II (due to defunct site I via Asp29Leu/Asp31Ala mutations) and a C-terminal structural domain (cCTnC, residues 84–161) with two high-affinity Ca²⁺/Mg²⁺ sites III/IV, connected by a flexible D/E linker; in apo/closed state, cNTnC is collapsed, but Ca²⁺ binding induces hydrophobic patch exposure (Met48, Met51, Leu75, Phe77) for cTnI switch peptide (residues 148–159) docking. Diastolic [Ca²⁺]i keeps cNTnC apo, with cTnI inhibitory region (residues 1–40) and mobile domain (164–210) blocking myosin-binding sites on actin via tropomyosin; systolic Ca²⁺ influx binds site II, opening cNTnC to recruit cTnI switch helix, releasing inhibition and shifting tropomyosin to myosin-permissive M-state, enabling force generation, PKA phosphorylation of cTnI Ser22/23 reduces Ca²⁺ sensitivity for lusitropy; mutations (e.g., HCM-linked A8V/A31S increase affinity via stabilized open state; DCM-linked G159D decrease via disrupted anchoring) cause myofilament Ca²⁺ dysregulation underlying hypertrophic/dilated cardiomyopathies, while circulating cTn complex serves as gold-standard biomarker for acute myocardial infarction.
    Riferimenti
    • https://pubmed.ncbi.nlm.nih.gov/26851561/
    • https://pubmed.ncbi.nlm.nih.gov/26232335/

    Supporto tecnico

    Istruzioni per la manipolazione

    Tel: +1-832-582-8158 Ext:3

    Per qualsiasi altra domanda, si prega di lasciare un messaggio.

    Si prega di inserire il proprio nome.
    Si prega di inserire la propria email. Si prega di inserire un indirizzo email valido.
    Si prega di scriverci qualcosa.